Mindfulness Meditation vs Escitalopram for Treatment of Anxiety Disorders Secondary Analysis of a Randomized Clinical Trial

Authors
Category Primary study
JournalJAMA NETWORK OPEN
Year 2024
This secondary analysis of a randomized clinical trial assesses patient-reported anxiety, depression, and quality of life among patients receiving mindfulness-based stress reduction vs escitalopram for the treatment of anxiety disorders.
Epistemonikos ID: 6ffa433352b55472ad941e1aed79def77cc697a7
First added on: Oct 10, 2024